BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3958775)

  • 21. Limitations of high dose intra-arterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) chemotherapy for malignant gliomas.
    Kapp J; Vance R; Parker JL; Smith RR
    Neurosurgery; 1982 Jun; 10(6 Pt 1):715-9. PubMed ID: 7110545
    [No Abstract]   [Full Text] [Related]  

  • 22. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients.
    Fernández-Hidalgo OA; Vanaclocha V; Vieitez JM; Aristu JJ; Rebollo J; Gúrpide A; Aramendía JM; Moreno-Palanques R; Martín-Algarra S; Subirá ML; Brugarolas A
    Bone Marrow Transplant; 1996 Jul; 18(1):143-9. PubMed ID: 8832007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase-I trial of intracarotid BCNU and cisplatin in patients with malignant intracerebral tumors.
    Feun LG; Wallace S; Yung WK; Lee YY; Leavens ME; Moser R; Savaraj N; Burgess MA; Plager C; Benjamin RS
    Cancer Drug Deliv; 1984; 1(3):239-45. PubMed ID: 6544123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nalbuphine and droperidol in combination for sedation and prevention of nausea and vomiting during intra-carotid BCNU infusion.
    Klein DS; Klein PW; Mahaley MS
    J Neurooncol; 1986; 3(4):323-5. PubMed ID: 3958777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracarotid BCNU for glioma.
    Wolpert SM
    Neurosurgery; 1987 Aug; 21(2):270. PubMed ID: 3658141
    [No Abstract]   [Full Text] [Related]  

  • 26. Intra-arterial BCNU chemotherapy for the treatment of malignant gliomas of the central nervous system: a preliminary report.
    Greenberg HS; Ensminger WD; Seeger JF; Kindt GW; Chandler F; Doan K; Dakhil SR
    Cancer Treat Rep; 1981; 65(9-10):803-10. PubMed ID: 7023671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of intracarotid or selective intracerebral infusion of cisplatin for treatment of recurrent anaplastic gliomas.
    Dropcho EJ; Rosenfeld SS; Vitek J; Guthrie BL; Morawetz RB
    J Neurooncol; 1998 Jan; 36(2):191-8. PubMed ID: 9525819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Internal carotid arterial BCNU perfusion in the treatment of cerebral glioma].
    Wu ZL
    Zhonghua Wai Ke Za Zhi; 1989 Jul; 27(7):421-3, 446. PubMed ID: 2598744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternating sequential intracarotid BCNU and cisplatin in recurrent malignant glioma.
    Rogers LR; Purvis JB; Lederman RJ; Rosenbloom SA; Tomsak RL; Estes ML; Magdinec M; Medendorp SV; Boyett JM
    Cancer; 1991 Jul; 68(1):15-21. PubMed ID: 2049736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experiences with sodium thiosulfate after intracarotid infusion of cisplatin and BCNU for malignant gliomas.
    Vance RB; Pittisapu J; Kapp JP
    J Neurooncol; 1986; 4(2):151-4. PubMed ID: 3783209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complications associated with intra-arterial BCNU administered in combination with vincristine and procarbazine for the treatment of malignant brain tumors.
    Bremer AM; Kleriga E; Nguyen TQ; Balsys R; Northup HM; Gonzalez N; Duarte P; Miller RI
    J Neurooncol; 1984; 2(2):129-32. PubMed ID: 6481425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central neurotoxicity following intracarotid BCNU chemotherapy for malignant gliomas.
    Mahaley MS; Whaley RA; Blue M; Bertsch L
    J Neurooncol; 1986; 3(4):297-314. PubMed ID: 3958776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Superselective arterial BCNU infusion in the treatment of patients with malignant gliomas.
    Clayman DA; Wolpert SM; Heros DO
    AJNR Am J Neuroradiol; 1989; 10(4):767-71. PubMed ID: 2549772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot clinical and pharmacokinetic study of intracarotid cisplatin and bleomycin.
    Feun LG; Savaraj N; Lee YY; Landy H; Martinez-Prieto J; Charnsangavej C; Post JD; Lee KF; Wallace S; Bowen B
    Sel Cancer Ther; 1991; 7(1):29-36. PubMed ID: 1718023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma.
    Rajkumar SV; Buckner JC; Schomberg PJ; Cascino TL; Burch PA; Dinapoli RP
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):297-302. PubMed ID: 9457812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system.
    Greenberg HS; Ensminger WD; Chandler WF; Layton PB; Junck L; Knake J; Vine AK
    J Neurosurg; 1984 Sep; 61(3):423-9. PubMed ID: 6747681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant chemotherapy with carmustine and cisplatin for patients with malignant gliomas.
    Yung WK; Janus TJ; Maor M; Feun LG
    J Neurooncol; 1992 Feb; 12(2):131-5. PubMed ID: 1560258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-irradiation internal carotid artery BCNU in treatment of glioblastoma multiforme.
    Bashir R; Hochberg FH; Linggood RM; Hottleman K
    J Neurosurg; 1988 Jun; 68(6):917-9. PubMed ID: 2836567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra-arterial cisplatin for the treatment of malignant gliomas.
    Newton HB; Page MA; Junck L; Greenberg HS
    J Neurooncol; 1989 May; 7(1):39-45. PubMed ID: 2547032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility study of intraarterial vs intravenous cisplatin, BCNU, and teniposide combined with systemic cisplatin, teniposide, cytosine arabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors.
    Stewart DJ; Grahovac Z; Hugenholtz H; DaSilva V; Richard MT; Benoit B; Belanger G; Russell N
    J Neurooncol; 1993 Jul; 17(1):71-9. PubMed ID: 8120574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.